Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India

Indian Journal of Medical Microbiology

Volumn 30, Issue 1, 2012, Pages 58-63

  Raveendran, R ^a   Wattal, C ^a   Oberoi, J K ^a   Goel, N ^a   Datta, S ^a   Prasad, K J ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

GenoType MTBDRplus; rapid diagnosis of multidrug resistant tuberculosis (MDRTB); tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; AUTOMATION; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOTYPE; INDIA; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR;

EID: 84857809750     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.93034     Document Type: Article

References (21)

1. Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: The automated nonradiometric systems. J Clin Microbiol 2006;44:20-8.
2. Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998;36:1969-73.
3. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635-40.
4. De Beenhouwer H, Lhiang Z, Jannes G, Mijs W, Machtelinckx L, Rossau R, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995;76:425-30.
5. Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000;4:481-4.
6. Bang D, Bengard Andersen A, Thomsen VO. Rapid genotypic detection of rifampin and isoniazid resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006;44:2605-8.
7. Gamboa F, Cardona PJ, Manterola JM, Lonca J, Matas L, Padilla E, et al. Evaluation of a commercial probe assay for detection of rifampicin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998;17: 189-92.
8. Tortoli E, Marcelli F. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampicin susceptibility. Eur J Clin Microbiol Infect Dis 2007;26:51-5.
9. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of GenoType MTBDR assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Itly. J Clin Microbiol 2006;44:2485-91.
10. Burnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-92.
11. Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Munzano J, Haba L, Roses S, et al. Genotype MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol 2008;46:3660-7.
12. Miotto P, Piana F, Cirillo DM, Migliori GB. Genotype MTBDRplus: A further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2008;46:393-4.
13. Rattan A, Kalia A, Ahmed N. Multidrug-resistant Mycobacterium tuberculosis: Molecular perspectives. Emerg Infect Dis 1998;4:195-209.
14. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-50.
15. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, et al. Analysis for limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001;39:636-41.
16. Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin and pyrazinamide in Mycobacterium tuberculosis. Respir Res 2001;2:164-8.
17. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998;79:3-29.
18. Lee AS, Teo AS, Wong SY. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2001;45:2157-9.
19. Mdluli K, Slayden RA, Zhu Y, Ramaswamy S, Pan X, Mead D, et al. Inhibition of a Mycobacterium tuberculosis betaketoacyl ACP synthase by isoniazid. Science 1998;280: 1607-10.
20. Sreevatsan S, Pan X, Zhang Y, Deretic V, Musser JM. Analysis of the oxyR-ahpC region in isoniazid-resistant and susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans animals in diverse localities. Animicrob Agents Chemother 1997;41:600-6.
21. Makinen J, Marttila HJ, Marjamaki M, Viljanen K, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44:350-2.